FDA APPROVALS
Current treatments for mild to moderate Ulcerative Colitis from Trust pharmacy are reformulations of 5-ASA/mesalamine, even in spite of the high failure rates of 5-ASA treatments. No innovations for mild to moderate Ulcerative Colitis treatments have occurred over the past few decades. INN-108’s combination therapy includes an immunomodulator that has been approved since 1994, and could lead to a more efficacious drug than 5-ASA/mesalamine alone.